Search results
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 14 hours agoIn the pivotal IMerge trial, 28% of patients treated with Rytelo achieved transfusion independence...
Stem Cells Fast Facts
KEYT 3 Santa Barbara· 3 days agoScientists believe that stem cell research can be used to treat medical conditions including Parkinson’s disease, spinal cord injury, stroke, burns,...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 5 days agoBioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based ...
Gene therapy and employee benefits: from science fiction to medical reality
BenefitsPRO· 6 days agoAt the rate research and approvals have been accelerating, the 2020s may be remembered as the decade...
After 34 years, Peninsula drug company wins 1st drug approval - San Francisco Business Times
The Business Journals· 1 day agoThe Foster City company's (Nasdaq: GERN) imetelstat — branded as Rytelo — was approved Thursday by the FDA for transfusion-dependent anemia in adult patients with lower risk ...
Children with autism have more gray matter in brain's outer layer than others
UPI· 1 day agoToddlers with autism have cerebral cortexes -- often referred to as "gray matter" -- that are...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Valley City Times Record· 5 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval ...
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
TipRanks via Yahoo Finance· 3 days agoThere are two sides to every coin. This holds particularly true for penny stocks, or tickers that...
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis...
Benzinga· 5 days agoIn heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety
HIV/AIDS Fast Facts – KION546
KION 46 Salinas· 3 days agoAcute infection, or acute retroviral syndrome, which can produce flu-like symptoms in the first month after infection. Clinical latency, or asymptomatic...